Cite

HARVARD Citation

    Kelly, R. et al. (2021). Real‐world use of first‐generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration‐resistant prostate cancer. BJU international. pp. 18-26. [Online]. 
  
Back to record